May 28, 2015 / 5:17 AM / 2 years ago

BRIEF-Formycon signs licensing agreement for FYB203 biosimilar

May 28 (Reuters) - Formycon AG :

* Announces signing of global out-licensing deal for its FYB203 biosimilar drug, with Santo Holding GmbH as licensing partner

* Formycon to receive success-based payments in triple-digit millions of euros Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below